INmune Bio, Inc. (INMB)
2.36
+0.12
(+5.36%)
USD |
NASDAQ |
Sep 02, 15:26
INmune Bio Market Cap : 65.26M for Sept. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 01, 2026 | 61.94M |
| August 31, 2026 | 63.60M |
| August 28, 2026 | 64.43M |
| August 27, 2026 | 66.37M |
| August 26, 2026 | 67.61M |
| August 25, 2026 | 67.20M |
| August 24, 2026 | 65.26M |
| August 21, 2026 | 64.16M |
| August 20, 2026 | 59.73M |
| August 19, 2026 | 61.67M |
| August 18, 2026 | 58.35M |
| August 17, 2026 | 58.90M |
| August 14, 2026 | 60.01M |
| August 13, 2026 | 57.52M |
| August 12, 2026 | 56.41M |
| August 11, 2026 | 57.52M |
| August 10, 2026 | 58.63M |
| August 07, 2026 | 57.66M |
| August 06, 2026 | 52.82M |
| August 05, 2026 | 52.54M |
| August 04, 2026 | 52.82M |
| August 03, 2026 | 49.18M |
| July 31, 2026 | 46.52M |
| July 30, 2026 | 47.06M |
| July 29, 2026 | 44.93M |
| Date | Value |
|---|---|
| July 28, 2026 | 45.46M |
| July 27, 2026 | 45.99M |
| July 24, 2026 | 43.07M |
| July 23, 2026 | 45.73M |
| July 22, 2026 | 48.92M |
| July 21, 2026 | 52.37M |
| July 20, 2026 | 52.90M |
| July 17, 2026 | 50.51M |
| July 16, 2026 | 55.03M |
| July 15, 2026 | 55.03M |
| July 14, 2026 | 53.70M |
| July 13, 2026 | 49.45M |
| July 10, 2026 | 51.58M |
| July 09, 2026 | 47.59M |
| July 08, 2026 | 45.73M |
| July 07, 2026 | 46.26M |
| July 06, 2026 | 44.26M |
| July 02, 2026 | 45.20M |
| July 01, 2026 | 44.66M |
| June 30, 2026 | 43.33M |
| June 29, 2026 | 43.07M |
| June 26, 2026 | 37.75M |
| June 25, 2026 | 39.61M |
| June 24, 2026 | 35.89M |
| June 23, 2026 | 37.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.90B |
| Oncolytics Biotech, Inc. | 108.56M |
| Sangamo Therapeutics, Inc. | 67.94M |
| Sarepta Therapeutics, Inc. | 2.442B |
| Anixa Biosciences, Inc. | 107.20M |
Market Cap Related Metrics
| Price to Book Value | 3.082 |
| Price | 2.36 |
| Earnings Yield | -29.34% |